AMRITA RAMPERTAAP: Open Payments
NPI 1750915203 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 20 payments from 8 companies in 2025. Trend: 2023 $760 · 2024 $183 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $114 |
| Novo Nordisk Inc | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| PFIZER INC. | 1 | $29 |
| Exact Sciences Corporation | 1 | $24 |
| Neurelis, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $21 |
Products named: CAPLYTA, UBRELVY, QULIPTA, Wegovy, FARXIGA, NURTEC ODT, Cologuard Collection Kit, VALTOCO.
Industry payments across VA — which companies pay providers there.
